SCHEMBL7658355

SCHEMBL7658355

O=C(O)C1c2occc2CCN1S(=O)(=O)c1ccc(Oc2ccc(-c3ccc(-n4ccnc4)cc3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.39
CYP19A1 P11511 6/20 0.39
ESR2 Q92731 4/20 0.39
ADH5 P11766 1/20 0.39
PORCN Q9H237 5/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MMP1 P03956 3/20 0.37
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 2/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661855 1.00 ESR1 (0.39) ESR1CYP19A1ESR2ADH5PORCN
SCHEMBL7654948 0.97 MMP1 (0.38) ESR1CYP19A1ESR2CYP2D6MMP1
Hydrochloric Acid SCHEMBL7654884 0.94 ADH5 (0.42) ESR1CYP19A1ESR2ADH5PORCN
SCHEMBL7651679 0.90 KDM4E (0.44) ESR1CYP19A1ESR2ADH5CYP3A4
SCHEMBL7674837 0.88 MMP1 (0.40) MMP1LMNASMN1; SMN2TSHRHTT
SCHEMBL7651141 0.88 MMP1 (0.40) MMP1LMNASMN1; SMN2TSHRHTT
SCHEMBL7659207 0.87 CHRNA7 (0.36) ESR1CYP19A1ESR2ADH5PORCN
SCHEMBL7654117 0.87 LMNA (0.35) MMP1LMNASMN1; SMN2TSHRHTT
SCHEMBL7659859 0.87 LMNA (0.39) MMP1LMNASMN1; SMN2TSHRHTT
SCHEMBL7656362 0.86 PSEN1 (0.41) ESR1CYP19A1CYP3A4CYP2D6MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6339092-B1 FOR THERAPY RHEUMATOID ARTHRITIS, ARTHROSIS, TUMOUR INVASION AND GROWTH, INCLUDING MALIGNANT SPREAD AND THE FORMATION OF METASTASES, ULCERATIONS, ATHEROSCLEROSIS ADIR ET COMPAGNIE (FR) 2002-01-15 US disclosed